Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Common Equity (2016 - 2025)

Historic Common Equity for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $1.2 billion.

  • HUTCHMED (China)'s Common Equity rose 6514.54% to $1.2 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.2 billion, marking a year-over-year increase of 6514.54%. This contributed to the annual value of $636.9 million for FY2022, which is 3873.39% down from last year.
  • Latest data reveals that HUTCHMED (China) reported Common Equity of $1.2 billion as of Q2 2025, which was up 6514.54% from $752.0 million recorded in Q2 2024.
  • HUTCHMED (China)'s Common Equity's 5-year high stood at $1.2 billion during Q2 2025, with a 5-year trough of $464.4 million in Q1 2021.
  • In the last 5 years, HUTCHMED (China)'s Common Equity had a median value of $825.9 million in 2022 and averaged $850.0 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Common Equity skyrocketed by 17617.51% in 2021, and later plummeted by 3873.39% in 2022.
  • HUTCHMED (China)'s Common Equity (Quarter) stood at $1.0 billion in 2021, then tumbled by 38.73% to $636.9 million in 2022, then rose by 25.62% to $800.0 million in 2023, then decreased by 6.0% to $752.0 million in 2024, then surged by 65.15% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q2 2025, $752.0 million for Q2 2024, and $800.0 million during Q2 2023.